BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 16965393)

  • 1. EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth.
    Iiizumi M; Hosokawa M; Takehara A; Chung S; Nakamura T; Katagiri T; Eguchi H; Ohigashi H; Ishikawa O; Nakamura Y; Nakagawa H
    Cancer Sci; 2006 Nov; 97(11):1211-6. PubMed ID: 16965393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit.
    Takehara A; Hosokawa M; Eguchi H; Ohigashi H; Ishikawa O; Nakamura Y; Nakagawa H
    Cancer Res; 2007 Oct; 67(20):9704-12. PubMed ID: 17942900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-expression of cysteine proteinase inhibitor cystatin 6 promotes pancreatic cancer growth.
    Hosokawa M; Kashiwaya K; Eguchi H; Ohigashi H; Ishikawa O; Furihata M; Shinomura Y; Imai K; Nakamura Y; Nakagawa H
    Cancer Sci; 2008 Aug; 99(8):1626-32. PubMed ID: 18754876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4.
    Takehara A; Eguchi H; Ohigashi H; Ishikawa O; Kasugai T; Hosokawa M; Katagiri T; Nakamura Y; Nakagawa H
    Cancer Sci; 2006 Nov; 97(11):1191-7. PubMed ID: 16918991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
    Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
    Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the tubulin tyrosine ligase-like family member 4 polyglutamylase in PELP1 polyglutamylation and chromatin remodeling in pancreatic cancer cells.
    Kashiwaya K; Nakagawa H; Hosokawa M; Mochizuki Y; Ueda K; Piao L; Chung S; Hamamoto R; Eguchi H; Ohigashi H; Ishikawa O; Janke C; Shinomura Y; Nakamura Y
    Cancer Res; 2010 May; 70(10):4024-33. PubMed ID: 20442285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.
    Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H
    Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of C2orf18, termed ANT2BP (ANT2-binding protein), as one of the key molecules involved in pancreatic carcinogenesis.
    Kashiwaya K; Hosokawa M; Eguchi H; Ohigashi H; Ishikawa O; Shinomura Y; Nakamura Y; Nakagawa H
    Cancer Sci; 2009 Mar; 100(3):457-64. PubMed ID: 19154410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma.
    Wente MN; Gaida MM; Mayer C; Michalski CW; Haag N; Giese T; Felix K; Bergmann F; Giese NA; Friess H
    Int J Oncol; 2008 Aug; 33(2):297-308. PubMed ID: 18636150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
    Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
    Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
    Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
    Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of aberrant maspin expression on the invasive ability of pancreatic ductal adenocarcinoma cells.
    Hong SN; Lee JK; Choe WH; Ha HY; Park K; Sung IK; Lee KT; Kim JJ; Rhee JC
    Oncol Rep; 2009 Feb; 21(2):425-30. PubMed ID: 19148518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A; Xue M; Jackson C; Smith RC
    Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Eph receptor A4 by 2,5-dimethylpyrrolyl benzoic acid suppresses human pancreatic cancer growing orthotopically in nude mice.
    Takano H; Nakamura T; Tsuchikawa T; Kushibiki T; Hontani K; Inoko K; Takahashi M; Sato S; Abe H; Takeuchi S; Sato N; Hiraoka K; Nishihara H; Shichinohe T; Hirano S
    Oncotarget; 2015 Dec; 6(38):41063-76. PubMed ID: 26516928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioredoxin is downstream of Smad7 in a pathway that promotes growth and suppresses cisplatin-induced apoptosis in pancreatic cancer.
    Arnold NB; Ketterer K; Kleeff J; Friess H; Büchler MW; Korc M
    Cancer Res; 2004 May; 64(10):3599-606. PubMed ID: 15150118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.
    Dancer J; Takei H; Ro JY; Lowery-Nordberg M
    Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
    Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
    Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of the human hedgehog-interacting protein (Hip) in the normal and diseased pancreas.
    Kayed H; Kleeff J; Esposito I; Giese T; Keleg S; Giese N; Büchler MW; Friess H
    Mol Carcinog; 2005 Apr; 42(4):183-92. PubMed ID: 15754313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between ECT2 gene expression and methylation change of ECT2 promoter region in pancreatic cancer.
    Zhang ML; Lu S; Zhou L; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):533-8. PubMed ID: 18842503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of ONECUT1 expression in human pancreatic cancer cells.
    Jiang X; Zhang W; Kayed H; Zheng P; Giese NA; Friess H; Kleeff J
    Oncol Rep; 2008 Jan; 19(1):157-63. PubMed ID: 18097590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.